Tokyo, Japan

Toshiaki Tojo

This inventor holds 3 USPTO granted patents. Top assignee: Daiichi Pharmaceutical Co., Ltd.. Active years: 1999-2001.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Toyko, JP (1999)
  • Tokyo, JP (2000 - 2001)

Company Filing History:


Years Active: 1999-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Toshiaki Tojo: Innovator in Antibacterial Compounds

Introduction

Toshiaki Tojo is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of chemistry, particularly in the development of antibacterial agents. With a total of 3 patents to his name, Tojo's work has had a notable impact on pharmaceutical innovations.

Latest Patents

Among his latest patents, Tojo has developed a production process for cyclic compounds. One of his inventions focuses on a compound represented by formula (III). Another significant patent involves a compound represented by formula (I) and a compound represented by formula (II), which are useful as antibacterial agents. This invention aims to provide a novel synthetic process that is inexpensive, short-step, and industrially advantageous for the production of these compounds.

Career Highlights

Tojo is associated with Daiichi Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in the pharmaceutical sector. His innovative approaches have contributed to the company's reputation for excellence in drug development.

Collaborations

Throughout his career, Tojo has collaborated with notable colleagues, including Toshifumi Akiba and Tutomu Ebata. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Toshiaki Tojo's contributions to the field of antibacterial compounds exemplify the importance of innovation in pharmaceuticals. His patents reflect a commitment to developing effective solutions for health challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…